Drugs / DD-25
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01702324 | Oct 2012 → Aug 2013 | psoriasis | Fortuderm Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DD-25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01702324 ↗ |
| Route | Topical | “A topical DD-25 cream at 0.025% concentration.” NCT01702324 ↗ |